Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid ; volume:15 ; number:1 ; day:2 ; month:2 ; year:2024 ; pages:1-16 ; date:12.2024
Nature Communications ; 15, Heft 1 (2.2.2024), 1-16, 12.2024

Creator: An, Jusung
Kim, Kyeonghwan
Lim, Ho Jae
Kim, Hye Yun
Shin, Jinwoo
Park, InWook
Cho, Illhwan
Kim, Hyeong Yun
Kim, Sunghoon
McLean, Catriona
Choi, Kyu Yeong
Kim, YoungSoo
Lee, Kun Ho
Kim, Jong Seung

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-024-44818-x

URN: urn:nbn:de:101:1-2024041212204786839757

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

An, Jusung
Kim, Kyeonghwan
Lim, Ho Jae
Kim, Hye Yun
Shin, Jinwoo
Park, InWook
Cho, Illhwan
Kim, Hyeong Yun
Kim, Sunghoon
McLean, Catriona
Choi, Kyu Yeong
Kim, YoungSoo
Lee, Kun Ho
Kim, Jong Seung
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Related objects

Reset password